New York, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Bioburden Testing Market Research Report by Product, by Test, by Application, by End User - Global ...
Richmond, Feb. 23, 2024 (GLOBE NEWSWIRE) -- According to MarketDigits, the Bioburden Testing Market was valued USD 1.2 Billion in 2023 and projected to reach USD 2.8 Billion by 2030, growing at a CAGR ...
As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...
The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...
The Global Bioburden Testing Market has been growing steadily at a CAGR of 12-15% due to increasing regulatory requirements and the rising focus on product safety. The market size is influenced by ...
Another driver contributing to the market growth is the growing emphasis on regulatory compliance. Regulatory authorities across the globe are imposing strict guidelines and regulations regarding ...
A company's contamination-control plan is an important document designed to formalize the rationale, methods, and validation of contamination-control procedures in a manufacturing facility. The author ...
When sterilizing medical devices, sterilization personnel rely on bioburden counts as part of determining and maintaining the sterilization process. In the following Q&A, Martell Winters, senior ...
Unprocessed bulk material harvested directly from the bioreactor should be tested for contamination prior to downstream processing. Biopharmaceutical products are manufactured in living systems, such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results